← Older revision
Revision as of 05:22, 29 October 2012
(4 intermediate revisions by one user not shown)
Line 16:
Line 16:
** Risk factors for [[atherosclerosis]] like [[hypertension]] and [[hyperlipidemia]] should be controlled
** Risk factors for [[atherosclerosis]] like [[hypertension]] and [[hyperlipidemia]] should be controlled
** Their use may also prolong survival by preventing progression of cardiac and cerebrovascular disease
** Their use may also prolong survival by preventing progression of cardiac and cerebrovascular disease
−
** [[Statins]]
may
reduce mortality in patients who have undergone an abdominal aortic aneurysm repair
{{cite journal |author=Kalyanasundaram A, Elmore JR, Manazer JR, ''et al.'' |title=Simvastatin suppresses experimental aortic aneurysm expansion |journal=[[Journal of Vascular Surgery]] |volume=43 |issue=1 |pages=117–24 |year=2006 |month=January |pmid=16414398 |doi=10.1016/j.jvs.2005.08.007 |url=}}
+
** [[Statins]]
−
+
*** May
reduce mortality in patients who have undergone an abdominal aortic aneurysm repair
{{cite journal |author=Kalyanasundaram A, Elmore JR, Manazer JR, ''et al.'' |title=Simvastatin suppresses experimental aortic aneurysm expansion |journal=[[Journal of Vascular Surgery]] |volume=43 |issue=1 |pages=117–24 |year=2006 |month=January |pmid=16414398 |doi=10.1016/j.jvs.2005.08.007 |url=}}
−
+
** [[Beta blockers]]
−
+
*** May have a beneficial effect on expansion of aneurysm from its effect on reduction of [[blood pressure]]. It is used routinely in patients with abdominal aortic aneurysm followed non-operatively
{{cite journal |author=Hirsch AT, Haskal ZJ, Hertzer NR, ''et al.'' |title=ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation |journal=[[Circulation]] |volume=113 |issue=11 |pages=e463–654 |year=2006 |month=March |pmid=16549646 |doi=10.1161/CIRCULATIONAHA.106.174526 |url=}}
−
[[
aspirin
]],
antibiotics
for possible [[chlamydia]] infection
+
*** Reduce aortic complications in patients with [[Marfan syndrome]]
−
* Assess for coronary, carotid and peripheral vascular disease
+
*** Slow progression of AAAs in hypertensive patients
+
*** In the absence of other indications for
[[
beta blocker
]]
s
,
the evidence is insufficient to recommend using them routinely for the sole purpose of slowing atherosclerotic aneurysm growth
+
* [[Aspirin]]
+
** The beneficial effects of [[aspirin]] on prevention of [[CAD]] and [[PAD]] outweighs its risk of causing [[bleeding]]
+
* Antibiotics
for possible [[chlamydia]] infection
+
* Assess for
[[CAD|
coronary
]]
,
[[Carotid artery disease|
carotid
]]
and
[[peripheral arterial disease|
peripheral vascular disease
]]
* Surveillance:
* Surveillance:
** 4 to 5.4 cm - monitor every 6 to 12 months
** 4 to 5.4 cm - monitor every 6 to 12 months
** 3 to 4 cm - monitor every 2 to 3 years
** 3 to 4 cm - monitor every 2 to 3 years
−
−
=== Acute pharmacotherapies ===
−
*Antimetalloproteases such as [[doxycycline]] and [[roxithromycin]] may halt aneurysm expansion
−
*Similarly, [[NSAID|non-steriod anti inflammatory drugs]] have shown to be beneficial in small studies
−
*[[Beta blocker]]s have numerous benefits in patients with cardiovascular disease
−
*:*Reduce aortic complications in patients with [[Marfan syndrome]]
−
*:*Slow progression of AAAs in hypertensive patients
−
*:*In the absence of other indications for [[beta blocker]]s, the evidence is insufficient to recommend using them routinely for the sole purpose of slowing atherosclerotic aneurysm growth
==References==
==References==